Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 101 Specimen Handling 82 pembrolizumab 78 enzalutamide 63 Nivolumab 60 Gemcitabine 54 Docetaxel 52 apalutamide 42 Radiosurgery 41 Abiraterone Acetate 40 Prednisone 39 Androgen Antagonists 39 Biopsy 37 darolutamide 36 Cisplatin 35 cabozantinib 33 Radiotherapy 32 Carboplatin 29 Pluvicto 28 enfortumab vedotin 27 abiraterone 27 Ipilimumab 25 Radiation 23 durvalumab 22 atezolizumab 22 Leuprolide 20 olaparib 19 X-Rays 19 Standard of Care 18 avelumab 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Plasma Exchange × Genitourinary × 90 days × Clear all

NCT07087860 2026-05-08

RECIPE-B1

Mayo Clinic

Phase 2 Recruiting

Urinary Bladder Neoplasms, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡